Pharma-Bio Serv (PBSV) Short-term Investments (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Short-term Investments for 12 consecutive years, with $6.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments fell 19.64% year-over-year to $6.7 million; the trailing twelve-month figure through Apr 2026 stood at $6.7 million (down 19.64% YoY), and the FY2025 full-year result was $7.5 million, up 25.05% from the prior year.
• Short-term Investments improved to $6.7 million in Q2 2026 per PBSV's latest filing, from $4.8 million in the prior quarter.
• Across five years, Short-term Investments topped out at $11.7 million in Q3 2023 and bottomed at $4.5 million in Q4 2023.
• Historically, Short-term Investments has averaged $7.2 million across 4 years, with a median of $6.7 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments jumped 80.98% in 2024, then sank 45.89% in 2025.
• Over 4 years, Short-term Investments stood at $4.5 million in 2023, then jumped by 31.93% to $6.0 million in 2024, then grew by 25.05% to $7.5 million in 2025, then declined by 10.63% to $6.7 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $6.7 million, $4.8 million, and $7.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.